Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.
Res Pract Thromb Haemost. 2022 Sep 16;6(6):e12802. doi: 10.1002/rth2.12802. eCollection 2022 Aug.
Res Pract Thromb Haemost. 2022.
PMID: 36176310
Free PMC article.
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.
Scully M, de la Rubia J, Pavenski K, Metjian A, Knöbl P, Peyvandi F, Cataland S, Coppo P, Kremer Hovinga JA, Minkue Mi Edou J, De Passos Sousa R, Callewaert F, Gunawardena S, Lin J.
Scully M, et al. Among authors: de passos sousa r.
J Thromb Haemost. 2022 Dec;20(12):2810-2822. doi: 10.1111/jth.15892. Epub 2022 Oct 21.
J Thromb Haemost. 2022.
PMID: 36138517
Free PMC article.
Clinical Trial.
Item in Clipboard
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura.
Bergstrand M, Hansson E, Delaey B, Callewaert F, De Passos Sousa R, Sargentini-Maier ML.
Bergstrand M, et al. Among authors: de passos sousa r.
J Clin Pharmacol. 2022 Mar;62(3):409-421. doi: 10.1002/jcph.1991. Epub 2021 Nov 29.
J Clin Pharmacol. 2022.
PMID: 34699078
Free PMC article.
Item in Clipboard
Cite
Cite